Login / Signup

Efficacy and safety of Brentuximab Vedotin in advanced cutaneous T-Cell lymphomas patients.

E PapadavidE KapniariL MarinosVasiliki A NikolaouA OikonomidiJ GeorgakopoulosA StratigosV KoulouliasV Pappa
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2019)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • hodgkin lymphoma
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors